Bioequivalence sites, ready for your study

Kargeno Research and Policy Hub, part of the KEMRI research network in Kisumu, Kenya, is an experienced clinical research site with a strong track record in clinical trials, bioequivalence and pharmacokinetic (PK) studies, observational and epidemiological studies, and implementation research. The site has an experienced multidisciplinary team, established participant recruitment and retention systems, robust regulatory and quality oversight processes, clinical and laboratory infrastructure, strong data management capabilities, and established community engagement networks. Kargeno has expertise across a broad range of therapeutic areas, including infectious diseases, HIV, vaccines, sexual and reproductive health, contraceptives, respiratory diseases, maternal, neonatal and child health, parasitology, oncology, psychiatry, and mental health. The site has experience working with diverse study populations, including adults, women of reproductive age, pregnant women, adolescents, and children. Kargeno has dedicated infrastructure and an established site set-up to support bioequivalence and PK studies, including dedicated domiciliary/overnight accommodation rooms suitable for participant confinement and controlled study procedures. This enables the site to support studies requiring intensive PK sampling, close clinical observation, frequent safety assessments, and controlled participant management. The site is supported by specialized Consultants of Record who provide appropriate clinical and specialist oversight, alongside trained and experienced research staff with expertise in clinical trial conduct, participant management, protocol-specific procedures, timed pharmacokinetic sampling, safety monitoring, specimen collection and processing, documentation, and data management. The site also has established processes for investigational product accountability, specimen handling, quality assurance, and regulatory compliance. Overall, Kargeno provides a flexible, well-established, and research-ready platform capable of supporting bioequivalence/PK studies and a broad range of clinical research from start-up through completion. Its combination of dedicated PK-ready infrastructure, domiciliary facilities, specialist clinical oversight, trained site personnel, participant recruitment capabilities, and strong operational and quality systems positions Kargeno as a capable partner for sponsors and CROs seeking to conduct high-quality clinical and bioequivalence research in Kenya.

TA: Infectious diseases, Sexual Reproductive health, Contraceptives, Vaccines, HIV, Oncology, Psychiatry, Mental health; Parasitology, Respiratory diseases, Maternal, Neonatal & Child Health

Nyanza Reproductive Health Society (NRHS) is a Kenyan organization focused on improving reproductive, maternal, sexual, and community health outcomes. It provides healthcare, education, outreach, research, and support services, including programs targeting underserved and marginalized communities. NRHS works with LGBTQI+ communities by promoting access to non-discriminatory, confidential, and stigma-free sexual and reproductive health and HIV services. It also supports community engagement, health education, HIV prevention, and referrals to help LGBTQI+ individuals access appropriate healthcare safely and with dignity.

TA: Infectious DIseases